{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:04:05Z","timestamp":1787069045805,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The immediate post-diagnosis period is a critical phase for cancer patients, marked by significant informational and emotional distress. Although pharmacists are well-positioned to provide support during this time, limited research has investigated patients\u2019 specific concerns and consultation needs immediately after diagnosis, particularly in differentiating between hospital and community pharmacists. This study aimed to clarify cancer patients' concrete concerns and consultation preferences immediately following diagnosis, with a focus on the respective roles of hospital and community pharmacists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A nationwide cross-sectional web-based survey was conducted among 1,031 adult cancer patients in Japan. Participants selected relevant concerns from a 21-item structured questionnaire across four domains: Cancer and Cancer Treatment (CCT), Cancer Pain and Palliative Care (CPPC), Medications Other Than Cancer Treatment (MOCT), and Daily Life During Cancer Treatment (DLCT). For each concern, participants indicated whether they preferred to consult hospital pharmacists, community pharmacists, or both. McNemar tests were used to compare paired proportions (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 89.2% of participants reported at least one concern at diagnosis. The most frequently reported concerns were treatment-related, including side effects (49.2%), treatment costs (48.0%), psychological distress (41.6%), and mechanisms of anticancer drugs (38.8%). Patients expressed significantly stronger preferences for consulting hospital pharmacists over community pharmacists on treatment-specific topics such as side effects (34.7% vs. 13.8%), drug mechanisms (39.3% vs. 18.5%), and medications to relieve physical discomfort (36.1% vs. 17.0%) [all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001]. In contrast, MOCT-related concerns, such as drug interactions and medication management, elicited similarly high consultation preferences for both pharmacist types (&gt;\u200940%). DLCT and CPPC-related concerns were associated with relatively lower consultation demands overall.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cancer patients experience diverse and substantial informational and emotional needs immediately after diagnosis. Hospital pharmacists are particularly valued for treatment-specific support, while both hospital and community pharmacists are seen as essential resources for broader medication-related concerns. Enhancing cooperation between hospital and community pharmacists, and strengthening pharmacist-led support tailored to patients' needs at diagnosis may significantly improve patient-centered care and quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40780-025-00467-w","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T16:28:54Z","timestamp":1752164934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cross-sectional survey on cancer patients\u2019 concerns and consultation needs with pharmacists at the time of initial diagnosis"],"prefix":"10.1186","volume":"11","author":[{"given":"Tomofumi","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunobu","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koharu","family":"Yubune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Terakado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"3","key":"467_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"467_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/09540261.2017.1288090","volume":"29","author":"R Caruso","year":"2017","unstructured":"Caruso R, Nanni MG, Riba MB, et al. The burden of psychosocial morbidity related to cancer: patient and family issues. Int Rev Psychiatry. 2017;29(5):389\u2013402. https:\/\/doi.org\/10.1080\/09540261.2017.1288090.","journal-title":"Int Rev Psychiatry"},{"issue":"10","key":"467_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.2490\/jjrmc.57.936","volume":"57","author":"K Muraoka","year":"2020","unstructured":"Muraoka K. Psychological acceptance\/adjustment in patients with cancer. Jpn J Rehabil Med. 2020;57(10):936\u201341. https:\/\/doi.org\/10.2490\/jjrmc.57.936.","journal-title":"Jpn J Rehabil Med"},{"issue":"1","key":"467_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2190\/UQ2G-UGV1-3PPC-6387","volume":"7","author":"AD Weisman","year":"1977","unstructured":"Weisman AD, Worden JW. The existential plight in cancer: significance of the first 100 days. Int J Psychiatry Med. 1977;7(1):1\u201315. https:\/\/doi.org\/10.2190\/UQ2G-UGV1-3PPC-6387.","journal-title":"Int J Psychiatry Med"},{"issue":"2","key":"467_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1300\/j077v26n02_01","volume":"26","author":"NA Hawkins","year":"2008","unstructured":"Hawkins NA, Pollack LA, Leadbetter S, et al. Informational needs of patients and perceived adequacy of information available before and after treatment of cancer. J Psychosoc Oncol. 2008;26(2):1\u201316. https:\/\/doi.org\/10.1300\/j077v26n02_01.","journal-title":"J Psychosoc Oncol"},{"issue":"2","key":"467_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3950\/jibiinkoka.113.45","volume":"113","author":"K Otani","year":"2010","unstructured":"Otani K, Utitomi Y. Psychological and mental care of cancer patients. Nippon Jibiinkoka Gakkai Kaiho. 2010;113(2):45\u201352. https:\/\/doi.org\/10.3950\/jibiinkoka.113.45.","journal-title":"Nippon Jibiinkoka Gakkai Kaiho"},{"issue":"2","key":"467_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5649\/jjphcs.39.77","volume":"39","author":"M Sudou","year":"2013","unstructured":"Sudou M, Morii H, Sakana M, et al. Introduction of pharmaceutical care and its effects in outpatients with cancer chemotherapy. Jpn J Pharm Health Care Sci. 2013;39(2):77\u201384. https:\/\/doi.org\/10.5649\/jjphcs.39.77.","journal-title":"Jpn J Pharm Health Care Sci"},{"issue":"10","key":"467_CR8","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1248\/yakushi.16-00169","volume":"136","author":"M Kimura","year":"2016","unstructured":"Kimura M. Investigation into the establishment of indicators for pharmaceutical intervention in cancer pharmacotherapy. Yakugaku Zasshi. 2016;136(10):1379\u201384. https:\/\/doi.org\/10.1248\/yakushi.16-00169.","journal-title":"Yakugaku Zasshi"},{"key":"467_CR9","doi-asserted-by":"publisher","unstructured":"Tanaka K, Hori A, Tachi T, et al. Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast cancer. J Pharm Health Care Sci. 2018;4(1). https:\/\/doi.org\/10.1186\/s40780-018-0105-3.","DOI":"10.1186\/s40780-018-0105-3"},{"issue":"33","key":"467_CR10","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.2217\/fon-2023-0335","volume":"19","author":"Y Kawasaki","year":"2023","unstructured":"Kawasaki Y, Hirai K, Nii M, et al. Actual situation of decision-making support from medical staff when cancer patients make treatment choices. Future Oncol. 2023;19(33):2263\u201372. https:\/\/doi.org\/10.2217\/fon-2023-0335.","journal-title":"Future Oncol"},{"issue":"2","key":"467_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5649\/jjphcs.34.156","volume":"34","author":"H Harikae","year":"2008","unstructured":"Harikae H, Yoshida H, Katayama H, et al. Research on pain control in cancer outpatients taking opioids dispensed by community pharmacies. Jpn J Pharm Health Care Sci. 2008;34(2):156\u201364. https:\/\/doi.org\/10.5649\/jjphcs.34.156.","journal-title":"Jpn J Pharm Health Care Sci"},{"key":"467_CR12","first-page":"53","volume":"11","author":"A Miura","year":"2009","unstructured":"Miura A, Onishi K. Analysis of the process of death acceptance in patients with advanced pancreatic cancer: a retrospective study of four patients who received cancer diagnosis. Mie Nurs J. 2009;11:53\u201361.","journal-title":"Mie Nurs J"},{"issue":"4","key":"467_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5649\/jjphcs.41.254","volume":"41","author":"M Imamura","year":"2015","unstructured":"Imamura M, Matsui Y, Katayama K, et al. Function of and need for a pharmaceutical outpatient clinic run by oncology pharmacy specialists. Jpn J Pharm Health Care Sci. 2015;41(4):254\u201365. https:\/\/doi.org\/10.5649\/jjphcs.41.254.","journal-title":"Jpn J Pharm Health Care Sci"},{"issue":"12","key":"467_CR14","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1248\/yakushi.15-00172","volume":"135","author":"Y Takano","year":"2015","unstructured":"Takano Y, Hanya M, Tatematsu M, et al. Qualitative research to investigate the needs of pharmacists and drug therapy of cancer patients. Yakugaku Zasshi. 2015;135(12):1387\u201395. https:\/\/doi.org\/10.1248\/yakushi.15-00172.","journal-title":"Yakugaku Zasshi"},{"issue":"1","key":"467_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.11434\/kyorinmed.46.27","volume":"46","author":"F Nagashima","year":"2015","unstructured":"Nagashima F. Advances in cancer chemotherapy and outpatient\/home-based cancer care. J Kyorin Med Soc. 2015;46(1):27\u20138. https:\/\/doi.org\/10.11434\/kyorinmed.46.27.","journal-title":"J Kyorin Med Soc."},{"key":"467_CR16","unstructured":"Ministry of Health, Labour and Welfare, Japan. Clinical training guidelines for pharmacists. 2024. https:\/\/www.jshp.or.jp\/activity\/jutakujigyo\/sotsugorinsho-guide-1.pdf. Accessed 11 Apr 2025."},{"issue":"1","key":"467_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.60408\/pco.21.1_6","volume":"21","author":"A Ikeshita","year":"2023","unstructured":"Ikeshita A, Sagara A, Azechi T, et al. Evaluation of the relationship between pregnant\/postpartum women\u2019s characteristics and pharmacy use experience in terms of consultation needs with pharmacists. J Pharm Commun. 2023;21(1):6\u201313. https:\/\/doi.org\/10.60408\/pco.21.1_6.","journal-title":"J Pharm Commun."},{"issue":"1","key":"467_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.69297\/jscpjjcp.11.1_1","volume":"11","author":"A Ikeshita","year":"2023","unstructured":"Ikeshita A, Sagara A, Azechi T, et al. Survey on sharing information about health products\/medicines between obstetricians and pregnant\/postpartum women toward supporting pregnant\/postpartum women by family pharmacy\/pharmacist. Jpn J Community Pharm. 2023;11(1):1\u20138. https:\/\/doi.org\/10.69297\/jscpjjcp.11.1_1.","journal-title":"Jpn J Community Pharm."},{"key":"467_CR19","unstructured":"Sugimoto M. Survey on the role of hospital pharmacists in outpatient cancer care. Kyoto, Japan: Department of Pharmacy, Kyoto University Hospital; 2024. https:\/\/mhlw-grants.niph.go.jp\/system\/files\/report_pdf\/%E5%88%A5%E6%B7%BB%E8%B3%87%E6%96%996.pdf. Accessed 10 Oct 2024."},{"issue":"4","key":"467_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1248\/yakushi.13-00216","volume":"134","author":"H Satoh","year":"2014","unstructured":"Satoh H, Miki A, Kazutoshi M, et al. Problems of collaboration between community and hospital pharmacists. Yakugaku Zasshi. 2014;134(4):563\u201374. https:\/\/doi.org\/10.1248\/yakushi.13-00216.","journal-title":"Yakugaku Zasshi"},{"key":"467_CR21","unstructured":"Ministry of Health, Labour and Welfare, Japan. Vision for securing safe and hopeful medical care. Tokyo, Japan: Ministry of Health, Labour and Welfare; 2008. https:\/\/www.mhlw.go.jp\/shingi\/2008\/06\/dl\/s0618-8a.pdf. Accessed 11 Apr 2025."},{"issue":"3","key":"467_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1248\/yakushi.123.163","volume":"123","author":"S Hayashi","year":"2003","unstructured":"Hayashi S. The expected role of community pharmacist in society. Yakugaku Zasshi. 2003;123(3):163\u201371. https:\/\/doi.org\/10.1248\/yakushi.123.163.","journal-title":"Yakugaku Zasshi"},{"key":"467_CR23","first-page":"27","volume":"32","author":"C Ihara","year":"2014","unstructured":"Ihara C, Miho N. Scaling and measurement of the image of pharmacists. Dep Bull Pap. 2014;32:27\u201350.","journal-title":"Dep Bull Pap"},{"issue":"1","key":"467_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5649\/jjphcs.49.20","volume":"49","author":"S Hirata","year":"2023","unstructured":"Hirata S, Onoue H, Kondo J, et al. Relationship between the work image of pharmacists and the evaluation of their contribution to the community through the penetration of pharmacist functions as indicated by the pharmacy vision for patients. Iryo Yakugaku. 2023;49(1):20\u20137. https:\/\/doi.org\/10.5649\/jjphcs.49.20.","journal-title":"Iryo Yakugaku"},{"key":"467_CR25","unstructured":"Ministry of Health, Labour and Welfare, Japan. Fundamental concepts and practical case studies for promoting team-based medical care. Tokyo, Japan: Team-based Medical Care Promotion Working Group, Ministry of Health, Labour and Welfare; 2011. https:\/\/www.mhlw.go.jp\/stf\/shingi\/2r9852000001ehf7-att\/2r9852000001ehgo.pdf. Accessed 11 Apr 2025."},{"issue":"2","key":"467_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2512\/jspm.14.127","volume":"14","author":"K Iino","year":"2019","unstructured":"Iino K, Nagaoka N, Nozawa K, et al. Actual conditions, challenges, and training needs regarding nurses\u2019 appearance care for cancer patients undergoing treatment. Palliat Care Res. 2019;14(2):127\u201338. https:\/\/doi.org\/10.2512\/jspm.14.127.","journal-title":"Palliat Care Res"},{"key":"467_CR27","unstructured":"Ministry of Health, Labour and Welfare, Japan. Vision of pharmacies for patients: from \"gatefront\" to \"family\" and \"community\"-based pharmacies. Tokyo, Japan: Ministry of Health, Labour and Welfare; 2015. https:\/\/www.mhlw.go.jp\/file\/04-Houdouhappyou-11121000-Iyakushokuhinkyoku-Soumuka\/vision_1.pdf. Accessed 11 Apr 2025."},{"issue":"6","key":"467_CR28","first-page":"241","volume":"89","author":"I Cifaldi","year":"1998","unstructured":"Cifaldi I, Bernardo MA, Marchei M, et al. Role of the oncologist in prevention, diagnosis and treatment of neoplasms. Minerva Med. 1998;89(6):241\u20136.","journal-title":"Minerva Med"},{"issue":"3","key":"467_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1188\/12.cjon.316-319","volume":"16","author":"LK Sheldon","year":"2012","unstructured":"Sheldon LK, Harris D, Arcieri C. Psychosocial concerns in cancer care: the role of the oncology nurse. Clin J Oncol Nurs. 2012;16(3):316\u20139. https:\/\/doi.org\/10.1188\/12.cjon.316-319.","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"467_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1248\/yakushi.23-00146","volume":"144","author":"N Matsumoto","year":"2024","unstructured":"Matsumoto N, Mizuno T, Aimiya Y, et al. Factors Related to Submission of Tracing Reports Regarding Cancer Chemotherapy by Pharmacy Pharmacists. Yakugaku Zasshi. 2024;144(1):143\u201350. https:\/\/doi.org\/10.1248\/yakushi.23-00146.","journal-title":"Yakugaku Zasshi"},{"issue":"5","key":"467_CR31","first-page":"879","volume":"36","author":"H Ishiguro","year":"2009","unstructured":"Ishiguro H, Koshiji M, Morizane T, et al. Drug interactions in medical oncology. Gan To Kagaku Ryoho. 2009;36(5):879\u201385.","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-025-00467-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T16:28:59Z","timestamp":1752164939000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphcs.biomedcentral.com\/articles\/10.1186\/s40780-025-00467-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["467"],"URL":"https:\/\/doi.org\/10.1186\/s40780-025-00467-w","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan. This study was approved by the Research Ethics Committee for Human Subjects at Hoshi University (Approval No: 2024\u201331; Date of approval: November 25, 2024).Participation in the survey was entirely voluntary, and informed consent was implied by completing and submitting the questionnaire. Respondents were explicitly informed that collected data would be anonymized to protect their privacy and would not be used for any purposes other than statistical analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\u201d in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}